ADCI Stock Overview
The Arab Drug Company engages in the manufacture and sale of pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
The Arab Drug Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م94.19 |
| 52 Week High | ج.م98.00 |
| 52 Week Low | ج.م55.00 |
| Beta | 0.65 |
| 1 Month Change | 7.40% |
| 3 Month Change | 19.50% |
| 1 Year Change | 57.11% |
| 3 Year Change | 40.50% |
| 5 Year Change | 181.75% |
| Change since IPO | 656.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADCI | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0.6% | 0.8% | -1.0% |
| 1Y | 57.1% | 32.1% | 60.7% |
Return vs Industry: ADCI exceeded the EG Pharmaceuticals industry which returned 35.9% over the past year.
Return vs Market: ADCI underperformed the EG Market which returned 67.8% over the past year.
Price Volatility
| ADCI volatility | |
|---|---|
| ADCI Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in EG Market | 13.3% |
| 10% least volatile stocks in EG Market | 4.8% |
Stable Share Price: ADCI's share price has been volatile over the past 3 months.
Volatility Over Time: ADCI's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1963 | n/a | R. Samah Abdel-Yassiz | www.adcopharma-eg.com |
The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco.
The Arab Drug Company Fundamentals Summary
| ADCI fundamental statistics | |
|---|---|
| Market cap | ج.م565.14m |
| Earnings (TTM) | ج.م74.29m |
| Revenue (TTM) | ج.م722.67m |
7.6x
P/E Ratio0.8x
P/S RatioIs ADCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADCI income statement (TTM) | |
|---|---|
| Revenue | ج.م722.67m |
| Cost of Revenue | ج.م474.41m |
| Gross Profit | ج.م248.26m |
| Other Expenses | ج.م173.97m |
| Earnings | ج.م74.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.38 |
| Gross Margin | 34.35% |
| Net Profit Margin | 10.28% |
| Debt/Equity Ratio | 116.5% |
How did ADCI perform over the long term?
See historical performance and comparison